{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:44:29Z","timestamp":1789911869933,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jdermsci.2016.12.006","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T18:34:03Z","timestamp":1480962843000},"page":"226-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments"],"prefix":"10.1016","volume":"85","author":[{"given":"Xijia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenna","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangchu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liucun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2016.12.006_bib0005","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0010","unstructured":"N. Jaimes, A.A. Marghoob, An update on risk factors, prognosis and management of melanoma patients. Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa italiana di dermatologia e sifilografia 147 (2012) 1\u201319."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0015","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1188\/15.CJON.430-432","article-title":"Nivolumab: immunotherapy in malignant melanoma","volume":"19","author":"Bayless","year":"2015","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0020","first-page":"132","article-title":"Survival analysis in patients with cutaneous malignant melanoma","volume":"125","author":"Radovic-Kovacevic","year":"1997","journal-title":"Srpski arhiv za celokupno lekarstvo"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0025","first-page":"13","article-title":"Your patient with melanoma: staging, prognosis, and treatment","volume":"23","author":"Rubin","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ad.2012.05.003","article-title":"Risk factors for the development of locoregional cutaneous metastases as the sole form of recurrence in patients with melanoma","volume":"104","author":"Messeguer","year":"2013","journal-title":"Actas dermo-sifiliograficas"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0167-7152(02)00030-5","article-title":"Survival estimation and testing via multiple imputation","volume":"58","author":"Taylor","year":"2002","journal-title":"Stat. Probab. Lett."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0040","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"Clark","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0045","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version 2009 of AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0050","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0055","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.12659\/MSM.891327","article-title":"Circulating miR-221 expression level and prognosis of cutaneous malignant melanoma","volume":"20","author":"Li","year":"2014","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0060","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CMR.0000000000000123","article-title":"EGFR and cyclin D1 in nodular melanoma: correlation with pathohistological parameters and overall survival","volume":"24","author":"Katunaric","year":"2014","journal-title":"Melanoma Res."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0065","doi-asserted-by":"crossref","first-page":"17683","DOI":"10.1038\/srep17683","article-title":"Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression","volume":"5","author":"Guo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0070","first-page":"11414","article-title":"Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0075","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.18632\/oncotarget.6446","article-title":"Long non-coding RNAs in colorectal cancer","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0080","doi-asserted-by":"crossref","first-page":"e0118728","DOI":"10.1371\/journal.pone.0118728","article-title":"Correction: long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation","volume":"10","author":"Staff","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11912-007-0054-8","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"9","author":"Margolin","year":"2007","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0090","first-page":"87","article-title":"Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm)","volume":"7","author":"Balch","year":"2000","journal-title":"Intergroup Melanoma Surg. Trial Ann. Surg. Oncol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0305-7372(03)00074-4","article-title":"Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials","volume":"29","author":"Wheatley","year":"2003","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/cam4.563","article-title":"Intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta-analysis of three trials","volume":"5","author":"Malczewski","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0110","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1200\/JCO.2013.53.1590","volume":"32","author":"Flaherty","year":"2014","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0115","first-page":"1389","article-title":"Toxicity of adjuvant high-dose interferon-alpha-2b in patients with cutaneous melanoma at high risk of recurrence","volume":"6","author":"Schachter","year":"1999","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2217\/imt.13.39","article-title":"Progress and potential of immune checkpoint blockade for treating advanced renal cell carcinoma","volume":"5","author":"Tykodi","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0125","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1158\/1078-0432.CCR-14-1187","article-title":"Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer","volume":"21","author":"Anagnostou","year":"2015","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-3-319-22539-5_9","article-title":"Checkpoint blockade for the treatment of advanced melanoma","volume":"167","author":"Callahan","year":"2016","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0001-4079(19)31343-3","article-title":"Drug therapy of melanoma: anti-CTLA-4 and anti-PD-1 antibodies","volume":"198","author":"Robert","year":"2014","journal-title":"Bulletin de l'Academie nationale de medecine"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0140","first-page":"662","article-title":"Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma","volume":"14","author":"Kahler","year":"2016","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft = J. Ger. Soc. Dermatol.: JDDG"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40425-015-0057-1","article-title":"Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma","volume":"3","author":"Laubli","year":"2015","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0150","first-page":"2015","article-title":"Late onset ipilimumab-induced pericarditis and pericardial effusion: a rare but life threatening complication","volume":"794842","author":"Yun","year":"2015","journal-title":"Case Rep. Oncol. Med."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0155","first-page":"A68","article-title":"The cancer genome atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp. Oncol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0160","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic Classification of Cutaneous Melanoma","volume":"161","author":"Cancer Genome Atlas N","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0165","doi-asserted-by":"crossref","first-page":"12297","DOI":"10.18632\/oncotarget.3655","article-title":"Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy","volume":"6","author":"Cirenajwis","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.3192","article-title":"The landscape of long noncoding RNAs in the human transcriptome","volume":"47","author":"Iyer","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0175","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2307\/2529872","article-title":"Nonparametric estimation of lifetime and disease onset distributions from incomplete observations","volume":"38","author":"Dinse","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0180","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother. Rep. Part 1"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0190","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/ijc.29619","article-title":"Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma","volume":"137","author":"Wagner","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13402-012-0080-x","article-title":"MMP2 expression is a prognostic marker for primary melanoma patients","volume":"35","author":"Rotte","year":"2012","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00432-012-1322-z","article-title":"A nine-gene signature predicting clinical outcome in cutaneous melanoma","volume":"139","author":"Brunner","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0205","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/jid.2013.58","article-title":"Prognostic significance of Fbw7 in human melanoma and its role in cell migration","volume":"133","author":"Cheng","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/carcin\/bgt346","article-title":"Prognostic significance of KAI1\/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4","volume":"35","author":"Tang","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0215","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1038\/jid.2012.193","article-title":"Role of Tip60 in human melanoma cell migration, metastasis, and patient survival","volume":"132","author":"Chen","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0220","doi-asserted-by":"crossref","first-page":"23026","DOI":"10.18632\/oncotarget.4854","article-title":"Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0225","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/jid.2015.200","article-title":"The CASC15 long intergenic noncoding RNA locus is involved in melanoma progression and phenotype switching","volume":"135","author":"Lessard","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0230","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.18632\/oncotarget.1863","article-title":"The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells","volume":"5","author":"Mazar","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0235","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.3892\/ijo.2014.2691","article-title":"Long non-coding RNAs drive metastatic progression in melanoma (Review)","volume":"45","author":"Akhbari","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0240","doi-asserted-by":"crossref","first-page":"e0145774","DOI":"10.1371\/journal.pone.0145774","article-title":"A genome wide study of copy number variation associated with nasopharyngeal carcinoma in malaysian chinese identifies CNVs at 11q14.3 and 6p21.3 as candidate loci","volume":"11","author":"Low","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0245","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11060-015-1718-0","article-title":"Altered expression of long non-coding RNAs during genotoxic stress-induced cell death in human glioma cells","volume":"122","author":"Liu","year":"2015","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0250","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1067\/msy.2001.115830","article-title":"Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma","volume":"130","author":"McMasters","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0255","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jso.2930440305","article-title":"Natural history and selective management of in transit melanoma","volume":"44","author":"Wong","year":"1990","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0260","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1245\/ASO.2003.09.016","article-title":"Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients","volume":"10","author":"Rousseau","year":"2003","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0265","first-page":"17","article-title":"Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guerin and hyperthermic perfusion","volume":"149","author":"Storm","year":"1979","journal-title":"Surg. Gynecol. Obstet."},{"key":"10.1016\/j.jdermsci.2016.12.006_bib0270","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/1078-0432.CCR-09-2721","article-title":"Melanoma MicroRNA signature predicts post-recurrence survival","volume":"16","author":"Segura","year":"2010","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116310234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116310234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T19:09:46Z","timestamp":1601233786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181116310234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0923181116310234"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.12.006","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}